Phase I Trial of 90-Dota-TYR3-Octreotide in Children W*

O'Dorisio, M. Sue Sue

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Food and Drug Administration (FDA)
• Type: Research Project (R01)
• Project #: 1R01FD002595-01
• Application #: 7095746
• Study Section: Special Emphasis Panel (ZFD1-OPD-L (01))
• Program Officer: Needleman, Katherine
• Project Start: 2005-07-01
• Project End: 2008-06-30
• Budget Start: 2005-07-01
• Budget End: 2006-06-30
• Support Year: 1
• Fiscal Year: 2005

Institution

• Name: University of Iowa
• Department: Pediatrics
• Type: Schools of Medicine
• DUNS #: 062761671
• City: Iowa City
• State: IA
• Country: United States
• Zip Code: 52242

Publications

Menda, Yusuf; O'Dorisio, M Sue; Kao, Simon et al. (2010) Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors. J Nucl Med 51:1524-31